Eltivutabart - CAS 2935496-38-9

Eltivutabart is a humanized monoclonal antibody targeting ENTPD1/CD39. It increases extracellular ATP and reduces immunosuppressive adenosine, thereby promoting antitumor immunity. It is suitable for studying metastatic pancreatic cancer.

Phosphatase

Metabolism

2935449

0.95

145.5

-20°C

Ice Packs

Inhibitory Antibodies